Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Prescription drug spending

The impact of age and chronic disease status

Dados Bibliográficos

ID11019001
AutoresC Mueller (0000-0002-3369-9124), Curt D Mueller (Project HOPE), Claudia L Schur (0000-0002-8358-2434), C Schur, Joan O’connell (0000-0003-3498-1153)
Ano1997
Volume87
Fascículo10
Páginas1626-1629
Data de publicação1997-10-01
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoAmerican Journal of Public Health (JOURNAL)
Identificadores do periódicoISSN: 0090-0036 • E-ISSN: 1541-0048
EditoraAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.87.10.1626
PMID9357343
OpenAlexW2086606120
IdiomaEN
Citações recebidas9
Referências citadas5

OBJECTIVES: The purpose of this study was to examine how pharmaceutical expenditures vary by age and the presence of chronic health problems. METHODS: Data from the 1987 National Medical Expenditure Survey were used to obtain nationally representative estimates of outpatient prescription drug expenditures for the noninstitutionalized population and the fraction of total health expenditures used to purchase medications for age-chronic disease population subgroups. RESULTS: Although the elderly make up 12% of the population, they account for 34% of total pharmaceutical expenditures. Pharmaceutical expenditures are 9% of total expenditures for children, 13% for nonelderly adults, and 23% for the elderly. Among nonelderly adults, approximately one third have at least one chronic condition and account for over two thirds of drug expenditures. Among the elderly, 36% have three or more chronic conditions and account for 57% of drug expenditures for this group; 41% of total drug expenditures are for cardiovascular or renal drugs. CONCLUSIONS: Significant pharmaceutical spending is for treatment of chronic conditions, which subjects insurance coverage to adverse selection and could affect the design of prescription drug benefit packages. Current enrollees in Medicare risk management plans who have drug benefits may face significantly higher out-of-pocket expenses for pharmaceuticals if capitation rates are cut as a means of controlling Medicare program expenditures

Chronic disease · Drug · Environmental health · Family medicine · Health care · Health insurance · Medical Expenditure Panel Survey · Medical prescription · Population · Prescription drug · Psychiatry · Health Systems, Economic Evaluations, Quality of Life · Medication Adherence and Compliance · Medicine · Pharmaceutical Economics and Policy · Pharmacology

  • Transferring the financial risks of pharmaceutical benefits from a large health care provider in Argentina to a consortium of pharmaceutical companies

    Open Access•Juan C Cervellino, Sandra B Corazza et al.•Revista Panamericana de Salud…•2003

  • The global burden of multiple chronic conditions

    Open Access•Cother Hajat, Emma Stein•Preventive Medicine Reports•2018

  • Clustering and Healthcare Costs With Multiple Chronic Conditions in a US Study

    Open Access•Cother Hajat, Yakir Siegal et al.•Frontiers in Public Health•2021

  • Assessing the effect of health status on multidimensional poverty among older adults

    Open Access•Lulin Zhou, Change Zhu et al.•Frontiers in Public Health•2023

  • Reducing Obesity Among People With Disabilities

    Open Access•Michael H Fox, Mary Helen Witten et al.•Journal of Disability Policy…•2013

  • Prescription Noncompliance due to Cost Among Adults With Disabilities in the United States

    Jae Kennedy, Christopher Erb et al.•American Journal of Public Health•2002

  • Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of Care

    John D Piette, Todd H Wagner et al.•Medical Care•2004

  • Impending widowhood and health care spending

    Open Access•Cathleen D Zick, Jessie X Fan et al.•Social Science Research•2004

  • Composição dos gastos privados com medicamentos utilizados por aposentados e pensionistas com idade igual ou superior a 60 anos em Belo Horizonte, Minas Gerais, Brasil

    Open Access•Marina Guimaraes Lima, Ma Teresa Casas Puig et al.•Cadernos de Saude Publica•2007

Obras citantes distintas9
Citações por ano0,38
Intervalo de citações2002 - 2023 (22)
Velocidade de citaçãohistorical
Altamente citadoNão
Tipos de citaçãoNeutras: 8
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae